REPORT COPYRIGHT VIOLATION IN REPLY
|
Message Subject
|
NEW STUDY: Eli Lilly, Regeneron antibody therapies lose out in effectiveness against Omicron variant
|
Poster Handle
|
Just Passing Through..... |
Post Content
|
Probably because Regenron isn't really effective in treating ADE masquerading around as Omnicron.
I really feel that there is a push amongst hospitals to label as many ADE or side effects as omnicron.
|
|
Please verify you're human:
|
|
Reason for copyright violation:
|